A Cell study on pediatric cancer reveals how age and tumor type shape immune responses. T cell activity and inflammation correlate with mutation rates. Findings aim to advance precision immunotherapy, improving treatment for children with cancer.
Read Full Article
#PediatricCancer #Immunotherapy #CancerResearch #TCellActivity #PrecisionMedicine
Read Full Article
#PediatricCancer #Immunotherapy #CancerResearch #TCellActivity #PrecisionMedicine
Cell
Systems-level immunomonitoring in children with solid tumors to enable precision medicine
In a population-based cohort of 191 children with diverse solid tumors, systems-level
analyses unravel immune variation with age and tumor type and provide a reference
for future precision immunotherapies tailored for the evolving immune systems of children.
analyses unravel immune variation with age and tumor type and provide a reference
for future precision immunotherapies tailored for the evolving immune systems of children.
A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy: Complete regression of hepatoblastoma, a malignant liver cancer and chemotherapy-resistant solid tumor, after CAR T cell treatment, achieved entirely in the outpatient setting without systemic toxicity.
Read Full Article
#CAR-T #PediatricCancer #Hepatoblastoma
Read Full Article
#CAR-T #PediatricCancer #Hepatoblastoma
ScienceAlert
A 3-Year-Old's Metastatic Cancer Disappeared After Two Doses of Experimental Therapy
This could save lives.
👍2👏2🕊1